Australia Biotechnology & Medical Research

Telix Pharmaceuticals Ltd (TLX)

Track

In the last 90 days, Telix Pharmaceuticals Ltd. saw two insider buy transactions totaling $996,738.45, all executed by MD & Group CEO Christian Behrenbruch. No sell transactions were recorded during this period. The stock has experienced a 31.9% price increase over the past 90 days.

Not featured in screeners

Featured in screeners

Not featured in screeners

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Behrenbruch Christian

MD & Group CEO

1 purchase — total 497,178 USD

Buy 29 Apr 2026

Value US$740,893.06 | Price 424.64 | Shares 95,325

Behrenbruch Christian

MD & Group CEO

1 purchase — total 499,560 USD

Buy 28 Apr 2026

Value US$2,781,840.83 | Price 225.02 | Shares 17,232

Dr Christian Behrenbruch

1 purchase — total 2,132,289 AUD

Buy 18 Jan 2024

Value A$2,132,289.00 | Price 13.91 | Shares 153,298

Dr Christian Behrenbruch

1 purchase — total 356,739 AUD

Buy 30 May 2023

Value A$356,738.94 | Price 2.97 | Shares 120,268

Tiffany Olson

1 purchase — total 343,385 AUD

Buy 16 Mar 2023

Value A$343,385.01 | Price 6.69 | Shares 51,305

Tiffany Olson

1 purchase — total 73,256 AUD

Buy 12 Dec 2022

Value A$73,255.51 | Price 6.70 | Shares 10,930

Dr Christian Behrenbruch

1 purchase — total 436,000 AUD

Buy 3 Feb 2022

Value A$436,000.00 | Price 1.09 | Shares 400,000

Dr Christian Behrenbruch

1 sale — total 15,400,000 AUD

Sale 27 Jan 2022

Value A$15,400,000.00 | Price 7.70 | Shares 2,000,000

Dr Andreas Kluge

1 sale — total 15,400,000 AUD

Sale 27 Jan 2022

Value A$15,400,000.00 | Price 7.70 | Shares 2,000,000

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-05-06	2026-04-29	B Purchase	Behrenbruch Christian MD & Group CEO Executive Director	95,325 -26.1% 424.64 US$740,893	95,325 -26.1%	424.64	US$740,893
2026-05-06	2026-04-28	B Purchase	Behrenbruch Christian MD & Group CEO Executive Director	17,232 -48.9% 225.02 US$2,781,841	17,232 -48.9%	225.02	US$2,781,841
2024-01-22	2024-01-18	B Purchase	Dr Christian Behrenbruch Director	1,426 467.76 A$2,333,354	1,426	467.76	A$2,333,354
2023-06-02	2023-05-30	B Purchase	Dr Christian Behrenbruch Director	120,268 2.97 A$356,739	120,268	2.97	A$356,739
2023-03-17	2023-03-16	B Purchase	Tiffany Olson Director	51,305 6.69 A$343,385	51,305	6.69	A$343,385
2022-12-15	2022-12-12	B Purchase	Tiffany Olson Director	10,930 6.70 A$73,256	10,930	6.70	A$73,256
2022-02-03	2022-02-03	B Purchase	Dr Christian Behrenbruch Director	400,000 1.09 A$436,000	400,000	1.09	A$436,000
2022-01-31	2022-01-27	S Sale	Dr Christian Behrenbruch Director	2,000,000 7.70 A$15,400,000	2,000,000	7.70	A$15,400,000
2022-01-31	2022-01-27	S Sale	Dr Andreas Kluge Director	2,000,000 7.70 A$15,400,000	2,000,000	7.70	A$15,400,000